FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/05/2025
Back to search
Official data from USPTO
PHARMAGENIC ENRICHMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PHARMAGENIC ENRICHMENT
ST13
US500000079389202Class
44
Filing
79389202
Registration
7772657
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
44
Filing date
01/17/2024
Registration date
04/29/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PolygenRx Pty Ltd
Representatives
Fatima Kassem Brooks Kushman P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Advisory services relating to pharmaceutical productsproviding information to patients in the field of administering medication; provision of pharmaceutical medical information; genetic testing for medical purposes; medical advisory services relating to medical problems; medical advisory services relating to medical services; alternative medical services; arranging of medical treatmentproviding medical treatment of chronic diseases in the nature of cardiometabolicinflammatoryneurologicalpsychiatricophthalmologicalmusculoskeletalrespiratoryoncologicalfibroticdermatologicalhepatic and renal diseases; cardiology medical services; complementary medical services; conducting of medical examinations; general practice (GP) medical services; fitness testingmedical testing for fitness evaluation; gastroenterology medical services; endocrinology medical services; dietetic counselling servicesdietic advisory services; medical consultancy and advisory services in relation to medical services; medical analysis of tissues for medical treatment for persons; health care consultancy services; health farm services in the nature of health spa services for health and wellness of the body and spirit offered at a health club facility; medical advice for individuals with disabilities; medical advisory services; medical analysis services relating to the treatment of patients; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis and treatment of persons; medical assistance; medical care services; medical clinic services; medical consulting services relating to offshore medical services; medical counselling; medical diagnostic services; medical examination of individuals; medical health assessment services; medical services in the field of oncology; medical screening; medical services; medical treatment servicesmedical treatment of cardiometabolicinflammatoryneurologicalpsychiatricophthalmologicalmusculoskeletalrespiratoryoncologicalfibroticdermatologicalhepatic and renal diseases; medical treatment using cultured cells; neurology medical services; oncology medical services; ophthalmology medical services; pediatric medical services; preparation of reports relating to medical matters in the nature of providing medical information to patientsmedical professionalsmedical providerspharmacistspathologistspathology service providersmedical payersincluding public and private health insurersmedical device distributorspharmaceutical distributorsbiotechnology companies in the form of reports in the field of complex traits and disorders relating to cardiometabolicinflammatoryneurologicalpsychiatricophthalmologicalmusculoskeletalrespiratoryoncologicalfibroticdermatologicalhepatic and renal diseasesincluding pharmaceutical-gene interactionspredictions of the magnitude of response to treatments and interventions; providing medical information including onlineabout medical services; provision of medical assistance; provision of medical facilitiesleasing of equipped medical facilities that medical professionals can use on an as-needed basis; provision of medical information; provision of medical services; provision of medical treatment of cardiometabolicinflammatoryneurologicalpsychiatricophthalmologicalmusculoskeletalrespiratoryoncologicalfibroticdermatologicalhepatic and renal diseases; services for the preparation of medical reports in the nature of providing medical information to patientsmedical professionalsmedical providerspharmacistspathologistspathology service providersmedical payersincluding public and private health insurersmedical device distributorspharmaceutical distributorsbiotechnology companies in the form of reports in the field of cardiometabolicinflammatoryneurologicalpsychiatricophthalmologicalmusculoskeletalrespiratoryoncologicalfibroticdermatologicalhepatic and renal diseases
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/19/2025
FIMP
FINAL DISPOSITION PROCESSED
11/19/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/29/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/26/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/29/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2025
RFNT
REFUSAL PROCESSED BY IB
09/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/16/2024
RFRR
REFUSAL PROCESSED BY MPU
08/16/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/08/2024
CNRT
NON-FINAL ACTION WRITTEN
08/07/2024
DOCK
ASSIGNED TO EXAMINER
07/30/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/10/2024
Continuous trademark protection
Get notified about every new filing that threatens PHARMAGENIC ENRICHMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.